Muscle Pharm Corporation (MSLPQ)

[fellowshort1]

This is what I got:

As of the prospectus there are 8,271,577 shares that will probably be issued as of the latest s-1 statement. Assuming that all the 150k shares were sold.

At the end of 2013 the total will be 8,434,077 (8,271,577+[1,250,000*.13]) only 13% of the stock compensation will be issued in 2013 and the rest will be issued in 2015.

At the end of 2015 there will be 9,521,577 shares outstanding assuming there will be no more dilution and or stock issue.

However if you are doing a earnings multiple model then you should only focus on the P/E that will be calculated by the weighted average number of fully diluted shares outstanding over the year. That will be approximately 7.8 million shares outstanding for the denominator in the EPS calculation.

My guess is that we will have 3.5 million in earnings, this will mean we will have approximately 45 cents EPS. Using a PVGO multiple prediction model I am thinking when we uplist we will have a P/E ratio of 54. This means that the intrinsic value for the company for the quarter should be $24.30 per share. For Fiscal year 2013 we should have 7 million in earnings in all four quarters, thus EPS of 90 cents. That means by the time the 10-k comes out we should see a intrinsic value of the company per share at $48.6 per share.

Just my opinion of course. Looks to be a good year for MSLP longs.